Adili Tsaba
Chief Tech/Sci/R&D Officer at VESSL Therapeutics Ltd.
Profile
Adili Tsaba is currently working as the Vice President-Regulatory & Clinical Affairs at VESSL Therapeutics Ltd.
Prior to this, Ms. Tsaba completed an undergraduate degree at Technion-Israel Institute of Technology in 1996.
Ms. Tsaba also pursued graduate studies at Technion-Israel Institute of Technology.
Adili Tsaba active positions
| Companies | Position | Start |
|---|---|---|
VESSL Therapeutics Ltd.
 VESSL Therapeutics Ltd. Medical SpecialtiesHealth Technology VESSL Therapeutics Ltd. develops cell-based therapies for large patient populations. Its solutions include MultiGeneAngio fo Peripheral Artery Disease and MultiGeneGraft for end-stage renal disease. The company was founded in August 2000 by Moshe Y. Flugelman and Basil S. Lewis and is headquartered in Haifa, Israel. | Chief Tech/Sci/R&D Officer | 2000-12-31 |
Training of Adili Tsaba
| Technion-Israel Institute of Technology | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
VESSL Therapeutics Ltd.
VESSL Therapeutics Ltd. Medical SpecialtiesHealth Technology VESSL Therapeutics Ltd. develops cell-based therapies for large patient populations. Its solutions include MultiGeneAngio fo Peripheral Artery Disease and MultiGeneGraft for end-stage renal disease. The company was founded in August 2000 by Moshe Y. Flugelman and Basil S. Lewis and is headquartered in Haifa, Israel. | Health Technology |
- Stock Market
- Insiders
- Adili Tsaba